opc 21268 has been researched along with ramipril in 2 studies
Studies (opc 21268) | Trials (opc 21268) | Recent Studies (post-2010) (opc 21268) | Studies (ramipril) | Trials (ramipril) | Recent Studies (post-2010) (ramipril) |
---|---|---|---|---|---|
133 | 3 | 6 | 2,151 | 606 | 509 |
Protein | Taxonomy | opc 21268 (IC50) | ramipril (IC50) |
---|---|---|---|
Angiotensin-converting enzyme | Homo sapiens (human) | 0.004 | |
Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.253 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aldred, KL; Burrell, LM; Hutchins, AM; Johnston, CI; Phillips, PA; Risvanis, J | 1 |
Aldred, KL; Burrell, LM; Johnston, CI; Naitoh, M; Phillips, PA; Risvanis, J; Rockell, MD | 1 |
2 other study(ies) available for opc 21268 and ramipril
Article | Year |
---|---|
Attenuation of genetic hypertension after short-term vasopressin V1A receptor antagonism.
Topics: Aging; Angiotensin-Converting Enzyme Inhibitors; Animals; Antidiuretic Hormone Receptor Antagonists; Blood Pressure; Body Weight; Female; Hypertension; Male; Piperidines; Quinolones; Ramipril; Rats; Rats, Inbred SHR | 1995 |
Modulation of genetic hypertension by short-term AVP V1A or V2 receptor antagonism in young SHR.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Pressure; Hypertension; Male; Myocardium; Organ Size; Piperidines; Quinolones; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Systole; Time Factors | 1997 |